IP Library Granted Patent US 8,163,015
Granted Patent B2
US 8,163,015 · App. 11/620,488 · Granted Apr 24, 2012

“W” accommodating intraocular lens

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,163,015
App. No.
11/620,488
Granted
Apr 24, 2012
Kind
B2
Abstract

An accommodating intraocular lens comprising a flexible body, a flexible optic which is moveable anteriorly and posteriorly relative to the lens body, and hinged portions longitudinally connecting the optic to the body. The body may have extending centration and fixation loops on its distal ends.

Claims (7)

1. An uniplanar accommodating intraocular lens (IOL) comprising a substantially flat elongated flexible lens body and a flexible optic, said lens body having a longitudinal axis and a width and defined by flat plate haptics, said flexible optic is asymmetrically and completely surrounded by the lens body and the periphery of the optic is suspended from the lens body by narrow flexible hinged straps, each strap is on an opposite side of the optic and longitudinal to the lens body and includes at least one hinge, the straps being approximately 0.5 mm long radially and approximately 0.25 mm thick and oriented along the longitudinal axis of the lens body so that the optic can move anteriorly and posteriorly upon ciliary muscle constriction and relaxation relative to the lens body, the lens body having thickened ends and having open fixation and centration loops from side to side on the thickened ends thereof, wherein the lens body has a single V-shaped hinge across the middle of the lens body width aligned with the center of the optic, and wherein the optic is constructed to optically deform with ciliary muscle contraction and vitreous pressure to enhance near vision.

2. A lens as in claim 1 wherein each strap has two hinges, each one on a different end of the strap.

3. A lens as in claim 1 wherein the lens body has an anterior side with the V-shaped hinge thereon.

4. A lens as in claim 1 wherein a posterior side of the lens body includes a ridge.

5. An uniplanar accommodating intraocular lens (IOL) comprising a substantially flat elongated flexible lens body and a flexible optic, said lens body having a longitudinal axis and a width and defined by flat plate haptics, said flexible optic is asymmetrically and completely surrounded by the lens body and the periphery of the optic is suspended from the lens body by narrow flexible hinged straps, each strap is on an opposite side of the optic and longitudinal to the lens body and includes at least one hinge, the straps being approximately 0.5 mm long radially and approximately 0.25 mm thick and oriented along the longitudinal axis of the lens body so that the optic can move anteriorly and posteriorly upon ciliary muscle constriction and relaxation relative to the lens body, the lens body having thickened ends and having open fixation and centration loops from side to side on the thickened ends thereof, wherein the lens body has a pair of V-shaped hinge across the middle of the lens body width aligned with the periphery of the optic, and wherein the optic is constructed to optically deform with ciliary muscle contraction and vitreous pressure to enhance near vision.

6. A lens as in claim 5 wherein each strap has two hinges, each one on a different end of the strap.

7. A lens as in claim 5 wherein a posterior side of the body includes a ridge.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMA POLAND SPOLKA Z ORGANICZONA ODPOWIEDZIALNOSCIA; VALEANT SP. Z.O.O.
Reel/Frame 073637/0222 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT PHARMACEUTICALS LUXEMBOURG S.À R.L.; VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA; VALEANT SP. Z O. O.
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →